Stock 1813 POLYLITE TAIWAN CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Polylite Taiwan Co., Ltd.

Equities

1813

TW0001813004

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 07/06/2024 am IST 		5-day change 1st Jan Change
20.45 TWD +0.74% Intraday chart for Polylite Taiwan Co., Ltd. 0.00% -1.68%
14/05 Polylite Taiwan Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
13/03 Polylite Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 890.7 1,264 895.4 848.8 1,063 970
Enterprise Value (EV) 1 709.5 1,278 1,001 894.9 1,136 1,056
P/E ratio 13.9 x 25.8 x -4,921 x -64.7 x 163 x 86.7 x
Yield 10.5% 3.69% - 2.75% 2.19% 2.4%
Capitalization / Revenue 1.94 x 2.53 x 2.01 x 1.88 x 2.94 x 2.69 x
EV / Revenue 1.54 x 2.56 x 2.24 x 1.98 x 3.14 x 2.93 x
EV / EBITDA 17.6 x 19.6 x 28.8 x 90.9 x -28.7 x -42 x
EV / FCF 8.26 x -9.26 x -47.2 x 32.9 x -32.7 x 38.9 x
FCF Yield 12.1% -10.8% -2.12% 3.04% -3.06% 2.57%
Price to Book 0.94 x 1.41 x 1.06 x 1.04 x 1.31 x 1.25 x
Nbr of stocks (in thousands) 46,635 46,635 46,635 46,635 46,635 46,636
Reference price 2 19.10 27.10 19.20 18.20 22.80 20.80
Announcement Date 22/03/19 17/03/20 11/03/21 25/03/22 28/03/23 13/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 459.4 498.9 445.9 451.1 362.1 360.5
EBITDA 1 40.23 65.2 34.7 9.845 -39.56 -25.16
EBIT 1 -32.58 -5.31 -40.57 -59.2 -104.6 -86.08
Operating Margin -7.09% -1.06% -9.1% -13.12% -28.9% -23.88%
Earnings before Tax (EBT) 1 41.83 42.21 -9.309 -30.28 -17.42 -10.03
Net income 1 63.92 49.14 -0.182 -13.13 6.712 11.2
Net margin 13.92% 9.85% -0.04% -2.91% 1.85% 3.11%
EPS 2 1.370 1.050 -0.003902 -0.2815 0.1400 0.2400
Free Cash Flow 1 85.9 -138 -21.19 27.24 -34.73 27.18
FCF margin 18.7% -27.66% -4.75% 6.04% -9.59% 7.54%
FCF Conversion (EBITDA) 213.52% - - 276.65% - -
FCF Conversion (Net income) 134.39% - - - - 242.71%
Dividend per Share 2 2.000 1.000 - 0.5000 0.5000 0.5000
Announcement Date 22/03/19 17/03/20 11/03/21 25/03/22 28/03/23 13/03/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 13.8 105 46.1 72.2 86.2
Net Cash position 1 181 - - - - -
Leverage (Debt/EBITDA) - 0.212 x 3.034 x 4.685 x -1.826 x -3.425 x
Free Cash Flow 1 85.9 -138 -21.2 27.2 -34.7 27.2
ROE (net income / shareholders' equity) 4.3% 3.96% 0.04% -2.93% -1.18% -0.55%
ROA (Net income/ Total Assets) -1.64% -0.29% -2.08% -2.92% -5.45% -4.92%
Assets 1 -3,901 -17,219 8.739 450 -123.2 -227.4
Book Value Per Share 2 20.30 19.20 18.20 17.40 17.40 16.60
Cash Flow per Share 2 4.610 2.540 4.060 5.950 3.840 2.550
Capex 1 3.09 112 22.5 18.6 15.9 9.47
Capex / Sales 0.67% 22.49% 5.04% 4.12% 4.39% 2.63%
Announcement Date 22/03/19 17/03/20 11/03/21 25/03/22 28/03/23 13/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Glasses, Spectacles & Contact Lenses

1st Jan change Capi.
POLYLITE TAIWAN CO., LTD. Stock Polylite Taiwan Co., Ltd.
-1.68% 29.4M
ESSILORLUXOTTICA Stock EssilorLuxottica
+13.88% 103B
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
-0.24% 18.79B
AUTEK CHINA INC. Stock Autek China Inc.
-22.28% 2.17B
WARBY PARKER INC. Stock Warby Parker Inc.
+17.94% 1.98B
PEGAVISION CORPORATION Stock Pegavision Corporation
+20.05% 1.14B
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-41.45% 679M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-7.76% 667M
MENICON CO., LTD. Stock Menicon Co., Ltd.
-45.13% 628M
SHANGHAI CONANT OPTICAL CO., LTD. Stock Shanghai Conant Optical Co., Ltd.
+56.94% 605M
Glasses, Spectacles & Contact Lenses
  1. Stock Market
  2. Equities
  3. 1813 Stock
  4. Financials Polylite Taiwan Co., Ltd.